EIB is providing up to €37.5 million in venture debt to Xeltis as part of a new €50 million financing package that will help bring aXess, the company’s regenerative vascular access conduit, to market.
Sponsored content FM Dental & Implant Centre co-founder Andrew Fish tells Emily Moore about a career which was inspired by ...
Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...
FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...
Hugh Jackman is a mere actor compared to Edward the wolverine, one of the toughest residents of San Francisco Zoo that became ...
VLADIMIR Putin’s scientists have launched a squadron of remote controlled spy pigeons fitted with brain implants. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback